SEC Form 4 · accession 0001144204-17-033475
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pellegrino Pionati
Officer — See Remarks
Period of report
Jun 15, 2017
Accepted (ET)
Jun 21, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2017 | F | 10,032 | $0.37 | D | 270,864 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock withheld to pay the Reporting Person's tax withholding obligations incurred in connection with the vesting of 30,000 shares of restricted stock on June 15, 2017.
Remarks
Chief Strategy and Marketing Officer